Evidence map›Paper›PMID 42840488›Full record

ArticleFrontiers in epigenetics and epigenomics2024

Benchmark of the Oxford Nanopore, EM-seq, and HumanMethylationEPIC BeadChip for the detection of the 5mC sites in cancer and normal samples.

Kseniia A Deinichenko, Valentina G Vynogradskaya, Pavel A Grebnev, Valeriya M Mikova, Dmitriy O Bobylev, Abusaid M Shaymardanov, Alexey A Ivashechkin, Marina V Erokhina, Alexandra I Akinshina, Anna V Semyanihina and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in epigenetics and epigenomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Kseniia A DeinichenkoFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Valentina G VynogradskayaFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Pavel A GrebnevFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Valeriya M MikovaFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Dmitriy O BobylevFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Abusaid M ShaymardanovFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Alexey A IvashechkinFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Marina V ErokhinaFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Alexandra I AkinshinaFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Anna V SemyanihinaFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Sergey I MitrofanovFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Konstantin S GrammatikatiFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Vladimir S YudinFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Sergey M YudinFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Antonida V MakhotenkoFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Anton A KeskinovFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Sergey A KraevoyFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Anna S MakarovaFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Ekaterina A SnigirFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Dmitry V SvetlichnyyFederal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
Veronika I SkvortsovaFederal Medical Biological Agency (FMBA of Russia), Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA methylationDNA methylation detectionDNA modificationenzymatic methyl-sequencingepigeneticsnanopore sequencing

Identifiers

PMID42840488
PMCPMC13639291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.